Palo Alto, California, March 10, 2011 – OroScience plc (Palo Alto, CA) announced today that it has entered into an agreement with New Line Medical, Inc. (Breaux Bridge, Louisiana) to market and distribute Periogenix™ periodontal wound dressing to clinicians in Louisiana and certain key markets in the broader Gulf States area.
Periogenix is a new oral wound dressing technology intended to protect injured periodontal tissue (gums) by forming a temporary physical barrier to avoid further irritation. Periogenix helps clinicians manage oral wounds by providing a barrier to assist in the process of acute and chronic wound healing. Clinical and animal studies demonstrate that Periogenix protects and safely promotes the healing of post-operative oral wounds.
“With over 1700 active dental accounts, New Line’s long standing relationships with dentists and dental specialists in Louisiana and the broader Gulf States area makes them a good fit to market and distribute Periogenix there” said Phil Houle, CEO of OroScience.
“Several of our leading dental customers have evaluated Periogenix, seeing excellent clinical results and expressing a level of excitement that we’ve rarely seen in our companies 19 years of selling dental products. Our initial sales progress is very encouraging, and we’re looking forward to significantly growing the market and increasing sales in our distribution area,” commented Richard Sawicki, President of New Line Medical, Inc.(www.newlinemedical.com)
About NewLine Medical, Inc.
New Line Medical, Inc. is an established dental and medical products distribution company headquartered in Louisiana with distribution along states on the Gulf Coast. New Line Medical is recognized as a preferred partner to dentists by the Louisiana and Mississippi Dental Associations.
About OroScience
OroScience is a global professional oral care company dedicated to providing advanced therapies for the professional management of oral conditions such as oral wounds and mucositis. Our mission, helping nature heal, is woven into the fabric of OroScience’s organization and vision. In collaboration with leading clinicians, we develop, manufacture, and sell proprietary therapeutic dental and oral care products for oral wound healing, tissue regeneration, and oral disease management.
**END OF PRESS RELEASE**
OroScience plc is an independent, stock exchange listed manufacturer of professional oral care products.
This news release may contain certain forward-looking statements, expectations, intentions, strategies and beliefs regarding the future. All statements contained herein are based upon information available to the management of OroScience plc as of the date hereof, and actual results may vary based upon future events, both within and without the control of the management, including risks and uncertainties that could cause actual results to differ materially.
Management does not take any responsibility to update the contents of this News Release in case new aspects arise or new conditions change the facts available.
OroScience plc
2275 East Bayshore Road, Suite 105
Palo Alto, CA 94303
ISIN IE00B40WCY19, WKN A0X9H7,
Exchange: Vienna stock exchange, Frankfurt Stock Exchange
Contacts
Media Contact:
OroScience
Phil Houle, 650-856-9600
Chief Executive Officer
phoule@oroscience.com
